Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chylomicron binding	LIPC GPIHBP1	4.60e-05	2	136	2	GO:0035478
GeneOntologyBiologicalProcess	cholesterol homeostasis	SEC24A ACSM1 SREBF2 APOB FABP3 LIPC GPIHBP1	1.51e-05	124	132	7	GO:0042632
GeneOntologyBiologicalProcess	sterol homeostasis	SEC24A ACSM1 SREBF2 APOB FABP3 LIPC GPIHBP1	1.60e-05	125	132	7	GO:0055092
GeneOntologyCellularComponent	Z disc	ANK2 ANK3 SYNM SYNPO KY XIRP2 KCNE1 HOMER1	7.39e-06	151	138	8	GO:0030018
GeneOntologyCellularComponent	costamere	ANK2 ANK3 SYNM HOMER1	1.21e-05	22	138	4	GO:0043034
GeneOntologyCellularComponent	I band	ANK2 ANK3 SYNM SYNPO KY XIRP2 KCNE1 HOMER1	1.48e-05	166	138	8	GO:0031674
GeneOntologyCellularComponent	postsynaptic density	ANK2 ANK3 MAP1B SYNPO PTPRZ1 PAK3 PLEKHA5 PRKCG GRIN3A HOMER2 HOMER1	2.06e-04	451	138	11	GO:0014069
GeneOntologyCellularComponent	sarcomere	ANK2 ANK3 SYNM SYNPO KY XIRP2 KCNE1 HOMER1	2.54e-04	249	138	8	GO:0030017
GeneOntologyCellularComponent	asymmetric synapse	ANK2 ANK3 MAP1B SYNPO PTPRZ1 PAK3 PLEKHA5 PRKCG GRIN3A HOMER2 HOMER1	3.32e-04	477	138	11	GO:0032279
GeneOntologyCellularComponent	myofibril	ANK2 ANK3 SYNM SYNPO KY XIRP2 KCNE1 HOMER1	4.69e-04	273	138	8	GO:0030016
GeneOntologyCellularComponent	postsynaptic specialization	ANK2 ANK3 MAP1B SYNPO PTPRZ1 PAK3 PLEKHA5 PRKCG GRIN3A HOMER2 HOMER1	5.18e-04	503	138	11	GO:0099572
GeneOntologyCellularComponent	contractile muscle fiber	ANK2 ANK3 SYNM SYNPO KY XIRP2 KCNE1 HOMER1	6.97e-04	290	138	8	GO:0043292
GeneOntologyCellularComponent	neuron to neuron synapse	ANK2 ANK3 MAP1B SYNPO PTPRZ1 PAK3 PLEKHA5 PRKCG GRIN3A HOMER2 HOMER1	7.15e-04	523	138	11	GO:0098984
GeneOntologyCellularComponent	postsynapse	GABRE CELF4 ANK2 ANK3 MAP1B NBEA SYNPO SLC9A5 PTPRZ1 PAK3 PLEKHA5 PRKCG GRIN3A HOMER2 HOMER1 CNTN1	1.13e-03	1018	138	16	GO:0098794
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A5 COL10A1	1.18e-03	8	138	2	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A5 COL10A1	1.18e-03	8	138	2	GO:0098645
MousePheno	abnormal motor coordination/balance	CTSF ANK2 ANK3 MAP1B HTRA2 TNC SHC1 OPA1 PREX2 YEATS2 KY KCNE1 PTPRZ1 LNPEP STARD9 PCDH15 NCOA1 PRKCG CAMTA1 EPHA10 CNTN1	2.00e-06	873	106	21	MP:0001516
MousePheno	ataxia	ANK3 MAP1B HTRA2 SHC1 OPA1 KCNE1 STARD9 PCDH15 PRKCG CAMTA1 CNTN1	5.42e-06	266	106	11	MP:0001393
MousePheno	abnormal CNS synaptic transmission	CELF4 EVC2 MBOAT1 ANK2 TNC WDR33 SHC1 NBEA SYNPO POGZ OPA1 KCNE1 PTPRZ1 NUFIP2 PAK3 PRKCG GRIN3A ST8SIA4 HOMER1 S1PR4	4.36e-05	985	106	20	MP:0002206
MousePheno	abnormal synaptic transmission	CELF4 EVC2 MBOAT1 ANK2 TNC WDR33 SHC1 NBEA SYNPO POGZ OPA1 KCNE1 PTPRZ1 NUFIP2 STON2 PAK3 PRKCG GRIN3A ST8SIA4 HOMER1 S1PR4	4.48e-05	1070	106	21	MP:0003635
MousePheno	abnormal synaptic physiology	CELF4 EVC2 MBOAT1 ANK2 TNC WDR33 SHC1 NBEA SYNPO POGZ OPA1 KCNE1 PTPRZ1 NUFIP2 STON2 PAK3 PRKCG GRIN3A ST8SIA4 HOMER1 S1PR4	4.86e-05	1076	106	21	MP:0021009
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	INTS1 RRBP1 STARD9 N4BP2 RTL9 NUFIP2 ZNF398 TMEM181 MUC20	1.31e-08	153	140	9	10718198
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	FN1 ANK3 SRPRA NBEA NUP214 RRBP1 TMEM87A OPA1 LOXHD1 XIRP2 TMPO PLEKHA5 HOMER1	1.22e-07	497	140	13	36774506
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	KIF18A MAP1B SRPRA SYNPO PIAS2 PHF21A YEATS2 VWA5A NUFIP2 TMPO JPT1 ZMYM1	2.70e-07	444	140	12	34795231
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B GPRASP1 ANK2 ANK3 NBEA SYNPO OPA1 N4BP2 NUFIP2 STON2 PAK3 PLEKHA5 PRKCG HOMER2 HOMER1 TP53BP1 CNTN1	3.69e-07	963	140	17	28671696
Pubmed	Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth.	TNC PTPRZ1 CNTN1	6.35e-07	5	140	3	12700241
Pubmed	Differential expression of phosphacan/RPTPbeta isoforms in the developing mouse visual system.	TNC PTPRZ1 CNTN1	6.35e-07	5	140	3	17722031
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ANK3 MAP1B WDR33 POGZ KIAA1671 YEATS2 TAF9B NUFIP2 TMPO PLEKHA5 SAP130 TP53BP1	2.48e-06	549	140	12	38280479
Pubmed	Mice develop normally without tenascin.	COL4A5 FN1 TNC	3.52e-06	8	140	3	1383086
Pubmed	A human MAP kinase interactome.	ANK3 SREBF2 RAP1GAP2 SYNPO NUP214 POGZ PIAS2 RIF1 N4BP2 PAK3 PLEKHA5	4.76e-06	486	140	11	20936779
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FN1 ANK2 ANK3 MAP1B TNC NBEA SYNPO FAM98B RRBP1 OPA1 PTPRZ1 NUFIP2 STON2 TMPO PLEKHA5 PRKCG HADH HOMER1 CNTN1	5.03e-06	1431	140	19	37142655
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ANK2 MAP1B NUP214 RRBP1 PHF21A GSR KIAA1671 YEATS2 RIF1 NUFIP2 NUP133 TMPO JPT1 PRR14L TP53BP1	5.89e-06	934	140	15	33916271
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	ANK2 ANK3 NBEA SYNPO PRKCG HOMER2 HOMER1 CNTN1	8.66e-06	251	140	8	27507650
Pubmed	Expression and roles of connective tissue growth factor in Meckel's cartilage development.	COL10A1 FN1 TNC	1.03e-05	11	140	3	15305294
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ANK3 NUP214 TGFB1I1 KIAA1671 XIRP2 STON2 ZMYM1 CAMTA1 SAP130 SMAD1	1.03e-05	430	140	10	35044719
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	KIF13B WDR33 INTS1 POGZ MED24 RIF1 NUFIP2 SAP130 TP53BP1	1.07e-05	341	140	9	32971831
Pubmed	Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex.	CELF4 ANK2 MAP1B HOMER2	1.20e-05	35	140	4	37758766
Pubmed	53BP1-RIF1: sculpting the DNA repair focus in 3D.	RIF1 TP53BP1	1.61e-05	2	140	2	31792447
Pubmed	Staphylococcal superantigen-like protein 8 (SSL8) binds to tenascin C and inhibits tenascin C-fibronectin interaction and cell motility of keratinocytes.	FN1 TNC	1.61e-05	2	140	2	23485472
Pubmed	No association of alcohol dependence with HOMER 1 and 2 genetic variants.	HOMER2 HOMER1	1.61e-05	2	140	2	20333726
Pubmed	Intrafamilial "DOA-plus" phenotype variability related to different OMI/HTRA2 expression.	HTRA2 OPA1	1.61e-05	2	140	2	31609081
Pubmed	Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells.	FN1 TNC	1.61e-05	2	140	2	28986537
Pubmed	Localization and expression of group I metabotropic glutamate receptors in the mouse striatum, globus pallidus, and subthalamic nucleus: regulatory effects of MPTP treatment and constitutive Homer deletion.	HOMER2 HOMER1	1.61e-05	2	140	2	17553998
Pubmed	Reciprocal Homer1a and Homer2 Isoform Expression Is a Key Mechanism for Muscle Soleus Atrophy in Spaceflown Mice.	HOMER2 HOMER1	1.61e-05	2	140	2	35008503
Pubmed	A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.	SREBF2 APOB	1.61e-05	2	140	2	16455790
Pubmed	Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia.	HOMER2 HOMER1	1.61e-05	2	140	2	16011574
Pubmed	Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.	FN1 TNC	1.61e-05	2	140	2	23313574
Pubmed	Transcriptional activity of multiple copies of a subtelomerically located olfactory receptor gene that is polymorphic in number and location.	OR4F4 OR4F17	1.61e-05	2	140	2	11689484
Pubmed	Comparative sequencing of a multicopy subtelomeric region containing olfactory receptor genes reveals multiple interactions between non-homologous chromosomes.	OR4F4 OR4F17	1.61e-05	2	140	2	11689483
Pubmed	Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis.	FN1 TNC	1.61e-05	2	140	2	20708078
Pubmed	Diagnostic Potential of Differentially Expressed Homer1 and Homer2 in Ischemic Stroke.	HOMER2 HOMER1	1.61e-05	2	140	2	27832625
Pubmed	Binding of tenascin-C to soluble fibronectin and matrix fibrils.	FN1 TNC	1.61e-05	2	140	2	7499434
Pubmed	Chylomicronemia elicits atherosclerosis in mice--brief report.	APOB GPIHBP1	1.61e-05	2	140	2	19815815
Pubmed	53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy.	RIF1 TP53BP1	1.61e-05	2	140	2	31822909
Pubmed	The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress.	RIF1 TP53BP1	1.61e-05	2	140	2	33141022
Pubmed	Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.	HTRA2 OPA1	1.61e-05	2	140	2	20064504
Pubmed	Imbalances in prefrontal cortex CC-Homer1 versus CC-Homer2 expression promote cocaine preference.	HOMER2 HOMER1	1.61e-05	2	140	2	23658151
Pubmed	Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.	FN1 TNC	1.61e-05	2	140	2	30451798
Pubmed	Influence of the -514C/T polymorphism in the promoter of the hepatic lipase gene on postprandial lipoprotein metabolism.	APOB LIPC	1.61e-05	2	140	2	15135253
Pubmed	Association of APOB and LIPC polymorphisms with type 2 diabetes in Chinese Han population.	APOB LIPC	1.61e-05	2	140	2	29883758
Pubmed	Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization.	FN1 TNC	1.61e-05	2	140	2	9482226
Pubmed	RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection.	RIF1 TP53BP1	1.61e-05	2	140	2	23333305
Pubmed	Interaction between ApoB and hepatic lipase mediates the uptake of ApoB-containing lipoproteins.	APOB LIPC	1.61e-05	2	140	2	9685400
Pubmed	Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.	SREBF2 LIPC	1.61e-05	2	140	2	15721010
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.61e-05	2	140	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.61e-05	2	140	2	25383926
Pubmed	De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.	FN1 TNC	1.61e-05	2	140	2	24792713
Pubmed	Expression and regulation of Homer in human skeletal muscle during neuromuscular junction adaptation to disuse and exercise.	HOMER2 HOMER1	1.61e-05	2	140	2	21885651
Pubmed	Homer1 promotes dendritic spine growth through ankyrin-G and its loss reshapes the synaptic proteome.	ANK3 HOMER1	1.61e-05	2	140	2	33398084
Pubmed	The interaction between F3 immunoglobulin domains and protein tyrosine phosphatases zeta/beta triggers bidirectional signalling between neurons and glial cells.	TNC CNTN1	1.61e-05	2	140	2	10103110
Pubmed	53BP1 regulates DSB repair using Rif1 to control 5' end resection.	RIF1 TP53BP1	1.61e-05	2	140	2	23306437
Pubmed	Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.	FN1 TNC	1.61e-05	2	140	2	20232238
Pubmed	Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population.	HOMER2 HOMER1	1.61e-05	2	140	2	16314758
Pubmed	The environmental and genetic evidence for the association of hyperlipidemia and hypertension.	SREBF2 APOB LIPC	1.77e-05	13	140	3	19155782
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ANK2 ANK3 NBEA SYNPO OPA1 PRKCG HOMER2 HOMER1	1.95e-05	281	140	8	28706196
Pubmed	Functional proteomics mapping of a human signaling pathway.	A2M KIF18A EVC2 FN1 ANK3 RRBP1 PIAS2 TGFB1I1 LNPEP SAP130 SMAD1	2.92e-05	591	140	11	15231748
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ANK2 ANK3 MAP1B SEC24A SRPRA NUP214 RRBP1 OPA1 DENND4C NUFIP2 TMPO PLEKHA5	3.14e-05	708	140	12	39231216
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	GABRE COL4A5 ANK3 MAP1B SREBF2 ATP9B SYNPO RRBP1 TECTA SPPL2B NBPF1 KIAA1671 YEATS2 DIP2C PAK3 CAMTA1 SAP130 TMEM181	3.17e-05	1489	140	18	28611215
Pubmed	Bone ridge patterning during musculoskeletal assembly is mediated through SCX regulation of Bmp4 at the tendon-skeleton junction.	COL10A1 TNC SMAD1	3.44e-05	16	140	3	20059955
Pubmed	Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers.	ANK2 PTPRZ1 CNTN1	3.44e-05	16	140	3	21745462
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RAP1GAP2 NUP214 POGZ OPA1 YEATS2 STARD9 NUFIP2 CAMTA1 TMEM181	4.28e-05	407	140	9	12693553
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	WDR33 SRPRA NUP214 RRBP1 DENND4C YEATS2 N4BP2 NUFIP2 ZFP1 PLEKHA5 PRR14L ZMYM1	4.39e-05	733	140	12	34672954
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC20	4.81e-05	3	140	2	30236127
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	4.81e-05	3	140	2	15611082
Pubmed	Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme.	FN1 TNC	4.81e-05	3	140	2	2440899
Pubmed	PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis.	HOMER2 HOMER1	4.81e-05	3	140	2	14528310
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC20	4.81e-05	3	140	2	26770020
Pubmed	Differential expression of Homer family proteins in the developing mouse brain.	HOMER2 HOMER1	4.81e-05	3	140	2	15116392
Pubmed	Homer is concentrated at the postsynaptic density and does not redistribute after acute synaptic stimulation.	HOMER2 HOMER1	4.81e-05	3	140	2	24530450
Pubmed	The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice.	APOB LIPC	4.81e-05	3	140	2	14679168
Pubmed	A high-carbohydrate diet effects on the A allele of hepatic lipase polymorphism on the apoB100/apoAI ratio in young Chinese males.	APOB LIPC	4.81e-05	3	140	2	23457133
Pubmed	Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1.	HTRA2 OPA1	4.81e-05	3	140	2	25531304
Pubmed	Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions.	FN1 TNC	4.81e-05	3	140	2	2461951
Pubmed	Isolation and characterization of fibronectin-alpha 1-microglobulin complex in rat plasma.	A2M FN1	4.81e-05	3	140	2	7519849
Pubmed	Expression of tenascin in developing and adult mouse lymphoid organs.	FN1 TNC	4.81e-05	3	140	2	7687262
Pubmed	Differential expression of micro-heterogeneous LewisX-type glycans in the stem cell compartment of the developing mouse spinal cord.	TNC PTPRZ1	4.81e-05	3	140	2	23624942
Pubmed	Homer proteins regulate sensitivity to cocaine.	HOMER2 HOMER1	4.81e-05	3	140	2	15294147
Pubmed	TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.	RIF1 TP53BP1	4.81e-05	3	140	2	28241136
Pubmed	Glypican-1, phosphacan/receptor protein-tyrosine phosphatase-ζ/β and its ligand, tenascin-C, are expressed by neural stem cells and neural cells derived from embryonic stem cells.	TNC PTPRZ1	4.81e-05	3	140	2	20689858
Pubmed	Distinct and Overlapping Expression Patterns of the Homer Family of Scaffolding Proteins and Their Encoding Genes in Developing Murine Cephalic Tissues.	HOMER2 HOMER1	4.81e-05	3	140	2	32070057
Pubmed	Mutation screening of the Homer gene family and association analysis in schizophrenia.	HOMER2 HOMER1	4.81e-05	3	140	2	12815733
Pubmed	Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.	A2M FN1	4.81e-05	3	140	2	27498393
Pubmed	Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.	FN1 TNC	4.81e-05	3	140	2	28652369
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK2 ANK3	4.81e-05	3	140	2	33410423
Pubmed	A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells.	PTPRZ1 CNTN1	4.81e-05	3	140	2	21969550
Pubmed	Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort.	ANK3 ACSM1	4.81e-05	3	140	2	20185149
Pubmed	Microsomal triglyceride transfer protein expression during mouse development.	APOB LIPC	4.81e-05	3	140	2	10744773
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK2 ANK3	4.81e-05	3	140	2	34289389
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC3A MUC20	4.98e-05	18	140	3	18834073
Pubmed	Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.	COL10A1 FN1 SMAD1	4.98e-05	18	140	3	35503090
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NUP214 POGZ PIAS2 DENND4C PHF21A KIAA1671 YEATS2 N4BP2 PLEKHA5	5.26e-05	418	140	9	34709266
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GPRASP1 ANK2 ANK3 MAP1B SRPRA NBEA SYNPO RRBP1 OPA1 NUFIP2 PITPNM3 PAK3 PRKCG HOMER1 TP53BP1	5.86e-05	1139	140	15	36417873
Pubmed	The Effect of the NFκB-USP9X-Cx43 Axis on the Dynamic Balance of Bone Formation/Degradation during Ossification of the Posterior Longitudinal Ligament of the Cervical Spine.	A2M MAP1B APOB DEFB125	6.80e-05	54	140	4	35391932
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	MAP1B SYNM NUP214 RIF1 NUP133 TMPO TP53BP1	7.27e-05	250	140	7	33536335
Pubmed	Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation.	ANK2 OPA1 FABP3 KCNE1	7.31e-05	55	140	4	27997827
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 MAP1B TNC NBEA SYNPO NUFIP2 PITPNM3 PRKCG	8.63e-05	347	140	8	17114649
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	ANK2 SEC24A FBF1 SRPRA NBEA TMEM87A LNPEP STARD9 TMPO	9.07e-05	449	140	9	31732153
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KIF18A ANK3 SEC24A SHC1 SRPRA NBEA OPA1 KIAA1671 RIF1 PTPRZ1 LNPEP NUFIP2 NUP133 TMPO	9.10e-05	1049	140	14	27880917
Pubmed	Negative modulation of androgen receptor transcriptional activity by Daxx.	PIAS2 TGFB1I1 NCOA1	9.30e-05	22	140	3	15572661
Pubmed	Glycosylphosphatidylinositol anchored recognition molecules that function in axonal fasciculation, growth and guidance in the nervous system.	CNTN5 CNTN1	9.60e-05	4	140	2	1838307
Pubmed	Dynamics of RIF1 SUMOylation is regulated by PIAS4 in the maintenance of Genomic Stability.	RIF1 TP53BP1	9.60e-05	4	140	2	29234018
Interaction	GRM5 interactions	GPRASP1 EVC2 PRKCG HOMER2 HOMER1	8.49e-06	43	131	5	int:GRM5
Interaction	FBXO22 interactions	FN1 ANK3 SRPRA NBEA NUP214 RRBP1 TMEM87A OPA1 LOXHD1 XIRP2 TMPO PLEKHA5 HOMER1 TP53BP1	1.15e-05	540	131	14	int:FBXO22
GeneFamily	Homer scaffolding proteins	HOMER2 HOMER1	7.83e-05	3	93	2	871
GeneFamily	CD molecules\|Mucins	MUC16 MUC3A MUC20	1.64e-04	21	93	3	648
GeneFamily	Fibronectin type III domain containing	FN1 TNC PTPRZ1 CNTN5 EPHA10 CNTN1	1.77e-04	160	93	6	555
GeneFamily	Olfactory receptors, family 4	OR4F4 OR4F5 OR4A15 OR4F17 OR4A4P	5.38e-04	129	93	5	151
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B KIF18A STARD9	1.70e-03	46	93	3	622
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	GPRASP1 CELF4 ANK2 ANK3 MAP1B RAP1GAP2 MUC16 AJAP1 VWA5A RTL9 PAK3 GRIN3A CNTN1	2.48e-06	506	136	13	M39067
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	ANK2 TNC SEC24A NBEA SYNPO PIAS2 YEATS2 RIF1 STARD9 NUP133 EMG1 PAK3 TMPO CAMTA1 ZNF385C ST8SIA4 HOMER2	1.74e-05	850	130	17	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	ANK3 MAP1B NUP214 ZBTB37 LNPEP GRIN3A ST8SIA4	3.74e-05	149	130	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPRASP1 TGFB1I1 STARD9 STON2 EMG1 DIP2C RELT SMAD1	2.14e-07	197	140	8	789c97ca9d1e28df3353140046047f11fbccc1d0
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELF4 MAP1B NBEA CNTN5 PAK3 PLEKHA5 HOMER1 CNTN1	2.22e-07	198	140	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M APOB LOXHD1 XIRP2 PCDH15 EPHA10 CNTN1	1.94e-06	184	140	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M APOB LOXHD1 XIRP2 PCDH15 EPHA10 CNTN1	1.94e-06	184	140	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M APOB LOXHD1 XIRP2 PCDH15 EPHA10 CNTN1	1.94e-06	184	140	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M GPRASP1 ANK3 PLXDC1 ZBTB37 STARD9 TMEM181	3.05e-06	197	140	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELF4 MAP1B NBEA PAK3 PLEKHA5 HOMER1 CNTN1	3.15e-06	198	140	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELF4 MAP1B NBEA PAK3 PLEKHA5 HOMER1 CNTN1	3.15e-06	198	140	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELF4 MAP1B NBEA PAK3 PLEKHA5 HOMER1 CNTN1	3.15e-06	198	140	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELF4 ANK3 MAP1B NBEA PAK3 PLEKHA5 CNTN1	3.15e-06	198	140	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2\|World / Primary Cells by Cluster	CELF4 ANK2 ANK3 MAP1B FABP3 NCOA1 CNTN1	3.26e-06	199	140	7	f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV\|World / Primary Cells by Cluster	CELF4 ANK2 ANK3 MAP1B FABP3 NCOA1 CNTN1	3.26e-06	199	140	7	e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CELF4 ANK3 MAP1B NBEA PAK3 PLEKHA5 CNTN1	3.37e-06	200	140	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A5 FN1 ANK3 MAP1B TNC TGFB1I1 PAK3	3.37e-06	200	140	7	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	CELF4 ANK2 TNC RAP1GAP2 FABP3 AJAP1 CNTN1	3.37e-06	200	140	7	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FN1 STARD9 CNTN5 GRIN3A CNTN1	1.76e-05	172	140	6	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FN1 STARD9 CNTN5 GRIN3A CNTN1	1.76e-05	172	140	6	553701349444eb366df3c11f54bb093434f153c6
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B SREBF2 RAP1GAP2 DENND4C KY PITPNM3	1.88e-05	174	140	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CELF4 ACSM1 CNTN5 MUC3A HOMER2 EPHA10	1.94e-05	175	140	6	19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175\|Adult / Lineage, Cell type, age group and donor	PLXDC1 PREX2 TGFB1I1 KIAA1671 GPIHBP1 SMAD1	2.07e-05	177	140	6	c9f269765c7d5d29caab75910e51645606ed562e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELF4 RTL4 PTPRZ1 PCDH15 PAK3 MUC20	2.20e-05	179	140	6	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELF4 RTL4 PTPRZ1 PCDH15 PAK3 MUC20	2.27e-05	180	140	6	8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ACSM1 GNPNAT1 DYRK4 PIAS2 PITPNM3 EPHA10	2.34e-05	181	140	6	8fcc9e77fee7c248df26b6c59b10e672242e2084
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FN1 MAP1B PLXDC1 TNC ACSM1 PREX2	2.42e-05	182	140	6	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M PREX2 KIAA1671 LOXHD1 GPIHBP1 GRIN3A	2.65e-05	185	140	6	602536a3308a848f106adcb0a83530997440c8f4
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL4A5 ANK2 TNC SYNPO AJAP1 PAK3	2.73e-05	186	140	6	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAP1B PLXDC1 SYNM PREX2 TGFB1I1 STARD9	2.90e-05	188	140	6	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 MAP1B KY NCOA1 HADH CNTN1	3.17e-05	191	140	6	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MAP1B SYNM PREX2 TGFB1I1 STARD9	3.17e-05	191	140	6	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MAP1B SYNM PREX2 TGFB1I1 STARD9	3.17e-05	191	140	6	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FN1 SYNPO PREX2 GPIHBP1 PTPRZ1	3.36e-05	193	140	6	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M COL4A5 FN1 TNC TGFB1I1 CNTN1	3.36e-05	193	140	6	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NBEA KY RIF1 NCOA1 HADH	3.56e-05	195	140	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CELF4 MAP1B AJAP1 PAK3 JPT1 CNTN1	3.66e-05	196	140	6	fe2dd3a93fe22da93e24a400e154a68757985fc8
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELF4 MAP1B NBEA PAK3 PLEKHA5 CNTN1	3.66e-05	196	140	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	frontal_cortex-Neuronal\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GPRASP1 CELF4 ANK3 MAP1B FABP3 PAK3	3.66e-05	196	140	6	de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCell	NS-moderate-d_07-13-Epithelial-Secretory\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MBOAT1 GNPNAT1 GSR PTPRZ1 HOMER2 SMAD1	3.66e-05	196	140	6	47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	CELF4 ANK3 FABP3 PRKCG GRIN3A CNTN1	3.76e-05	197	140	6	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M MAP1B SYNM AJAP1 PAK3 CNTN1	3.76e-05	197	140	6	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	A2M GPRASP1 FN1 MAP1B LRRC74A CNTN1	3.76e-05	197	140	6	2cb1f557ce1400398975de94638126b4522567f3
ToppCell	Fibroblast\|World / shred by cell class for bronchial biopsy	A2M FN1 MAP1B PLXDC1 SYNM TGFB1I1	3.76e-05	197	140	6	8bf9846228b6b6721b10375fe54a2fb389ff64a6
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M MAP1B PLXDC1 TNC TGFB1I1 AJAP1	3.76e-05	197	140	6	452be45f4aac8459dd860493171f5f715368d663
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M KIF13B FN1 ANK3 TNC PLEKHA5	3.76e-05	197	140	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FN1 MAP1B TNC RRBP1 PLEKHA5	3.87e-05	198	140	6	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FN1 MAP1B TNC RRBP1 PTPRZ1	3.87e-05	198	140	6	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	moderate-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GNPNAT1 SRPRA RRBP1 TMEM87A GSR MUC20	3.87e-05	198	140	6	7ecce5e266bb08797088cc8f8309e0c7b48df5c9
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)\|390C / Donor, Lineage, Cell class and subclass (all cells)	A2M FN1 MAP1B TNC FABP3 TGFB1I1	3.87e-05	198	140	6	c82a151f9f1477d4a401457173b8d72af776c137
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	A2M FN1 MAP1B TNC FABP3 TGFB1I1	3.87e-05	198	140	6	dc63b56bb6291e527b172d603569376286262845
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Lymphatic\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	GABRE SYNM SHC1 KIAA1671 STON2 SMAD1	3.98e-05	199	140	6	88f33b8dcd837abfa1d12c28719e073a7da6e979
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GABRE SYNM SHC1 KIAA1671 STON2 SMAD1	3.98e-05	199	140	6	64b19aff72e2a109cb5857cb248bd4712dd49b43
ToppCell	ASK452-Mesenchymal-Fibroblast\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	A2M FN1 ANK2 MAP1B PLXDC1 GNPNAT1	3.98e-05	199	140	6	4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A5 FN1 MAP1B TNC TGFB1I1 PAK3	3.98e-05	199	140	6	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	A2M SYNM SYNPO OR5M11 TECTA LOXHD1	3.98e-05	199	140	6	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FN1 MAP1B TNC RRBP1 PTPRZ1	3.98e-05	199	140	6	7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	A2M FN1 MAP1B SYNM TECTA TGFB1I1	3.98e-05	199	140	6	8ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCell	ASK452-Mesenchymal\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	A2M FN1 ANK2 MAP1B PLXDC1 GNPNAT1	3.98e-05	199	140	6	93e85e3731a9ece9aee3eb82c5dfdad331ee62d6
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B TNC SHC1 TGFB1I1 LOXHD1 SMOX	3.98e-05	199	140	6	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FN1 MAP1B TNC RRBP1 PTPRZ1	3.98e-05	199	140	6	f2ad641f36c577ff7019e88ad6b73ed7e46d8c74
ToppCell	ILEUM-non-inflamed-(8)_Smooth_muscle_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	A2M COL4A5 FN1 MAP1B TGFB1I1 CNTN1	3.98e-05	199	140	6	3368c0a90a47c4dcdfe70be3192550df0744e508
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GABRE SYNM SHC1 KIAA1671 STON2 SMAD1	3.98e-05	199	140	6	2b9e1e069b36b3a61cc3e384f4523687b0e03905
ToppCell	5'-Adult-SmallIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M FN1 ANK2 MAP1B FABP3 TGFB1I1	4.10e-05	200	140	6	a637281d91e95734ee4f8510b3780e0272b16fda
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAP1B PLXDC1 SYNM NBEA TGFB1I1 CNTN1	4.10e-05	200	140	6	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 SREBF2 MUC16 NBEA KIAA1671 HOMER2	4.10e-05	200	140	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FN1 MAP1B SYNPO PREX2 GPIHBP1	4.10e-05	200	140	6	93e13937ec74418a697c37d56f57509fb2154780
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	ANK2 ANK3 MAP1B NBEA FABP3 CNTN1	4.10e-05	200	140	6	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	ANK2 ANK3 MAP1B NBEA FABP3 CNTN1	4.10e-05	200	140	6	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LIPC VWA5A STON2 PCDH15 GRIN3A ST8SIA4	4.10e-05	200	140	6	107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	CELF4 ANK2 ANK3 MAP1B NBEA PAK3	4.10e-05	200	140	6	68c90376e2779434e4ad8dc6dd3b44baa700e2f4
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal\|10w / Sample Type, Dataset, Time_group, and Cell type.	CELF4 ANK2 ANK3 MAP1B NBEA PAK3	4.10e-05	200	140	6	979258173b82f37aeaaedd53b4a527da1dbe1b80
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1B PLXDC1 NBEA TGFB1I1 STARD9 CNTN1	4.10e-05	200	140	6	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M COL10A1 FN1 MAP1B TNC PCDH15	4.10e-05	200	140	6	07641f476cb1a131c2a50258b88cc13bb38c8379
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	A2M COL10A1 FN1 MAP1B TNC PCDH15	4.10e-05	200	140	6	343fa6ba1f52d816d2e41466f674ff8360aecd81
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 RAP1GAP2 MUC16 NBEA RRBP1 HOMER2	4.10e-05	200	140	6	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	(5)_Fibroblast-B_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CTSF COL10A1 FN1 MAP1B TNC TGFB1I1	4.10e-05	200	140	6	9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M COL10A1 FN1 MAP1B TNC PCDH15	4.10e-05	200	140	6	d0c00cdd52c2e001aec9b935f4e981ba77d0386a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 NBEA RRBP1 PTPRZ1 HOMER2 MGAM2	4.10e-05	200	140	6	85c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	MUC16 ADGRG4 PREX2 CNTN5 PCDH15	7.81e-05	139	140	5	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SYNPO LIPC AJAP1 PRKCG HOMER1	8.93e-05	143	140	5	5fb5a4ea93e5cce55d427e3b4a50a979504fad3c
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 GSR LNPEP STON2 CNTN1	1.05e-04	148	140	5	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 GSR LNPEP STON2 CNTN1	1.05e-04	148	140	5	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	PBMC-Severe-cDC_3\|Severe / Compartment, Disease Groups and Clusters	RPGRIP1 SYNM AJAP1 GTF2IRD2 ZNF398	1.19e-04	152	140	5	1a3f8ed476aa9a39742b4684be2c704669e4a3d0
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CTSF TGFB1I1 SLC9A5 TAF9B HADH	1.34e-04	156	140	5	60f1ce38e34b582f589db1e0d6139282c1902b2b
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M FN1 TNC PCDH15 CNTN1	1.51e-04	160	140	5	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M FN1 TNC PCDH15 CNTN1	1.51e-04	160	140	5	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FN1 CNTN5 GRIN3A CNTN1	1.56e-04	161	140	5	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	BL-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAM98B APLF GSR TGFB1I1 TMEM181	1.60e-04	162	140	5	25ec9df914445b4daae4fd28fd0e60b64797c46d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FN1 TTC23L GPIHBP1 PITPNM3	1.65e-04	163	140	5	1feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC23L RMDN2 TGFB1I1 MUC20 AFG1L	1.65e-04	163	140	5	b83a35c4426d66b5734a98fa6c72b345fe462030
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A5 DALRD3 NBPF1 TAF9B ZMYM1	1.65e-04	163	140	5	13f76f2979558f5cd27fbfd1659b413b3cac18f5
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC23L RMDN2 TGFB1I1 MUC20 AFG1L	1.65e-04	163	140	5	c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SREBF2 PHF21A GTF2IRD2 PAK3 ZMYM1	1.75e-04	165	140	5	7c771f22b58989572c939ed127e637ec28dc0dca
ToppCell	Endothelial-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK2 MAP1B SYNM PREX2 LOXHD1	1.80e-04	166	140	5	c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL10A1 FN1 MAP1B TNC MUC20	1.85e-04	167	140	5	805129f887078340b260aa136b0ba19f2bd6ea03
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL10A1 FN1 MAP1B TNC MUC20	1.85e-04	167	140	5	31cf8bf2eb523f6e7e319620648ff37fc09e2601
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL10A1 FN1 MAP1B TNC MUC20	1.85e-04	167	140	5	3acb18428d1d33ad430c2fd031b1a91baee3c01d
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK2 ANK3 MAP1B PTPRZ1 DIP2C	1.90e-04	168	140	5	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CELF4 PLXDC1 PTPRZ1 SMAD1 CNTN1	2.06e-04	171	140	5	ea60d9e9df28ab991fbdb596784b44f6a9fc5827
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SREBF2 SLC35E2B LNPEP PRR14L SAP130	2.06e-04	171	140	5	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	HTRA2 FABP3 TGFB1I1 KIAA1671 TAF9B	2.12e-04	172	140	5	9dca1542145d88559527db7e0f6ad150df59ca2d
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	GPRASP1 SPPL2B ZFP1 SAP130 AFG1L	2.18e-04	173	140	5	efb8072475000888efe088d00e870c56ffad4172
Disease	reaction time measurement	CELF4 RAP1GAP2 PHF21A PTPRZ1 N4BP2 CNTN5 NUFIP2 PITPNM3 NCOA1 GRIN3A CAMTA1 CNTN1 AFG1L	8.52e-06	658	132	13	EFO_0008393
Disease	Nonsyndromic Deafness	TNC TECTA LOXHD1 PCDH15 HOMER2	3.24e-05	81	132	5	C3711374
Disease	Hypercholesterolemia, Familial	SREBF2 APOB LIPC	6.80e-05	18	132	3	C0020445
Disease	nephrotic syndrome (biomarker_via_orthology)	A2M APOB SMAD1	1.65e-04	24	132	3	DOID:1184 (biomarker_via_orthology)
Disease	chordin-like protein 1 measurement	RTL9 PAK3	1.97e-04	5	132	2	EFO_0020257
Disease	myeloperoxidase measurement	RRBP1 MED24 NUP133	2.11e-04	26	132	3	EFO_0005243
Disease	anxiety disorder	OR8A1 ST8SIA4 MGAM2	3.25e-04	30	132	3	EFO_0006788
Disease	1-palmitoyl-GPE (16:0) measurement	LIPC TP53BP1	4.11e-04	7	132	2	EFO_0800245
Disease	long QT syndrome (is_implicated_in)	ANK2 KCNE1	4.11e-04	7	132	2	DOID:2843 (is_implicated_in)
Disease	Hereditary hearing loss and deafness	COL4A5 TECTA LOXHD1 KCNE1 PCDH15	5.17e-04	146	132	5	cv:C0236038
Disease	Focal glomerulosclerosis	COL4A5 FN1 SYNPO	5.61e-04	36	132	3	C0017668
Disease	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	COL4A5 SYNPO	7.00e-04	9	132	2	C4049702
Disease	Hypercholesterolemia	APOB LIPC GPIHBP1	7.11e-04	39	132	3	C0020443
Disease	myocardial infarction (biomarker_via_orthology)	FN1 TNC OPA1 GSR HADH	7.83e-04	160	132	5	DOID:5844 (biomarker_via_orthology)
Disease	diabetes mellitus (is_marker_for)	FN1 APOB GSR	8.24e-04	41	132	3	DOID:9351 (is_marker_for)
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	ANK2 KCNE1	8.73e-04	10	132	2	C1631597
Disease	triglycerides in large LDL measurement	APOB LIPC TP53BP1	9.47e-04	43	132	3	EFO_0022319
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB LIPC TP53BP1	9.47e-04	43	132	3	EFO_0022290
Disease	hearing impairment	COL4A5 TECTA LOXHD1 PCDH15	9.99e-04	98	132	4	C1384666
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	MAP1B EPHA10	1.06e-03	11	132	2	DOID:0050564 (is_implicated_in)
Disease	beta thalassemia (is_marker_for)	APOB GSR	1.06e-03	11	132	2	DOID:12241 (is_marker_for)
Disease	saturated fatty acids measurement	APOB LIPC TP53BP1	1.08e-03	45	132	3	EFO_0022304
Disease	Colorectal Carcinoma	EVC2 FN1 ANK2 MAP1B APOB PREX2 CCNB3 DIP2C ST8SIA4 CNTN1	1.26e-03	702	132	10	C0009402
Disease	triglycerides to total lipids in medium LDL percentage	APOB LIPC TP53BP1	1.47e-03	50	132	3	EFO_0022334
Disease	cholesteryl esters to total lipids in IDL percentage	APOB LIPC TP53BP1	1.47e-03	50	132	3	EFO_0022247
Disease	Hyperlipoproteinemia Type IIb	APOB LIPC	1.50e-03	13	132	2	C1704417
Disease	triglycerides to total lipids in large LDL percentage	APOB LIPC TP53BP1	1.56e-03	51	132	3	EFO_0022331
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	TECTA LOXHD1 PCDH15	1.56e-03	51	132	3	cv:CN043650
Disease	phospholipids in very small VLDL measurement	APOB LIPC TP53BP1	1.56e-03	51	132	3	EFO_0022300
Disease	triglycerides in HDL measurement	APOB LIPC TP53BP1	1.74e-03	53	132	3	EFO_0022317
Disease	atrial fibrillation (is_implicated_in)	ANK2 KCNE1	1.74e-03	14	132	2	DOID:0060224 (is_implicated_in)
Disease	triglycerides in medium HDL measurement	APOB LIPC TP53BP1	1.84e-03	54	132	3	EFO_0022321
Disease	Cocaine-Related Disorders	ATP9B HOMER2 HOMER1 SMAD1	1.92e-03	117	132	4	C0236736
Disease	triglycerides in very large HDL measurement	APOB LIPC TP53BP1	1.94e-03	55	132	3	EFO_0022324
Disease	phospholipids in medium HDL measurement	APOB LIPC GPIHBP1	1.94e-03	55	132	3	EFO_0022295
Disease	low density lipoprotein triglyceride measurement	APOB LIPC	2.01e-03	15	132	2	EFO_0009946
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB LIPC	2.01e-03	15	132	2	EFO_0022328
Disease	triglycerides in large VLDL measurement	APOB LIPC TP53BP1	2.04e-03	56	132	3	EFO_0022178
Disease	triglycerides in LDL measurement	APOB LIPC TP53BP1	2.04e-03	56	132	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	APOB LIPC TP53BP1	2.04e-03	56	132	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	APOB LIPC TP53BP1	2.04e-03	56	132	3	EFO_0022333
Disease	cholesteryl esters to total lipids in medium HDL percentage	APOB LIPC TP53BP1	2.04e-03	56	132	3	EFO_0022251
Disease	triglycerides in IDL measurement	APOB LIPC TP53BP1	2.26e-03	58	132	3	EFO_0022149
Disease	total lipids in medium HDL measurement	APOB LIPC GPIHBP1	2.26e-03	58	132	3	EFO_0022310
Disease	free cholesterol in medium HDL measurement	APOB LIPC GPIHBP1	2.26e-03	58	132	3	EFO_0022267
Disease	Hyperlipoproteinemia Type IIa	APOB LIPC	2.29e-03	16	132	2	C0745103
Disease	Romano-Ward Syndrome	ANK2 KCNE1	2.29e-03	16	132	2	C0035828
Disease	triglycerides to total lipids in small LDL percentage	APOB LIPC TP53BP1	2.37e-03	59	132	3	EFO_0022337
Disease	phospholipids in VLDL measurement	APOB LIPC TP53BP1	2.37e-03	59	132	3	EFO_0022301
Disease	phospholipids in small VLDL measurement	APOB LIPC TP53BP1	2.49e-03	60	132	3	EFO_0022146
Disease	triglycerides to total lipids in large HDL percentage	APOB LIPC TP53BP1	2.49e-03	60	132	3	EFO_0022330
Disease	cholesterol to total lipids in IDL percentage	APOB LIPC TP53BP1	2.49e-03	60	132	3	EFO_0022233
Disease	Lipidemias	APOB LIPC	2.58e-03	17	132	2	C1706412
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB LIPC	2.58e-03	17	132	2	EFO_0022232
Disease	Hyperlipidemia	APOB LIPC	2.58e-03	17	132	2	C0020473
Disease	Cocaine Abuse	ATP9B HOMER2 HOMER1 SMAD1	2.59e-03	127	132	4	C0009171
Disease	triglycerides in small VLDL measurement	APOB LIPC TP53BP1	2.61e-03	61	132	3	EFO_0022145
Disease	free cholesterol in VLDL measurement	APOB LIPC TP53BP1	2.61e-03	61	132	3	EFO_0022276
Disease	phospholipids in HDL measurement	APOB LIPC GPIHBP1	2.61e-03	61	132	3	EFO_0022293
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	APOB LIPC TP53BP1	2.61e-03	61	132	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	triglycerides in small HDL measurement	APOB LIPC TP53BP1	2.73e-03	62	132	3	EFO_0022158
Disease	triglycerides in medium LDL measurement	APOB LIPC TP53BP1	2.73e-03	62	132	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	APOB LIPC TP53BP1	2.73e-03	62	132	3	EFO_0022339
Disease	triglycerides to total lipids in IDL percentage	APOB LIPC TP53BP1	2.86e-03	63	132	3	EFO_0022329
Disease	total lipids in HDL measurement	APOB LIPC GPIHBP1	2.86e-03	63	132	3	EFO_0022307
Disease	transient cerebral ischemia (implicated_via_orthology)	HTRA2 OPA1 GSR	2.99e-03	64	132	3	DOID:224 (implicated_via_orthology)
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	APOB RRBP1 LIPC GPIHBP1 OR4A15 TP53BP1	3.00e-03	315	132	6	EFO_0004612, EFO_0008591
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	APOB RRBP1 LIPC GPIHBP1 OR4A15 TP53BP1	3.00e-03	315	132	6	EFO_0004574, EFO_0004612
Disease	triglycerides in small LDL measurement	APOB LIPC TP53BP1	3.12e-03	65	132	3	EFO_0022323
Disease	cerebral infarction (is_marker_for)	A2M APOB	3.23e-03	19	132	2	DOID:3526 (is_marker_for)
Disease	Malignant neoplasm of breast	FN1 ANK2 SREBF2 NUP214 TECTA RIF1 N4BP2 NUP133 DIP2C NCOA1 SMOX TP53BP1	3.25e-03	1074	132	12	C0006142
Disease	total lipids in small VLDL	APOB LIPC TP53BP1	3.40e-03	67	132	3	EFO_0022148
Disease	total lipids in large VLDL	APOB LIPC TP53BP1	3.40e-03	67	132	3	EFO_0022175
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	APOB LIPC TP53BP1	3.40e-03	67	132	3	EFO_0008595, EFO_0020946
Disease	cholesterol to total lipids in very small VLDL percentage	APOB LIPC TP53BP1	3.40e-03	67	132	3	EFO_0022245
Disease	triglycerides in very small VLDL measurement	APOB LIPC TP53BP1	3.55e-03	68	132	3	EFO_0022144
Disease	Cocaine Dependence	ATP9B HOMER2 HOMER1 SMAD1	3.58e-03	139	132	4	C0600427
Disease	triglycerides to total lipids in very small VLDL percentage	APOB LIPC TP53BP1	3.70e-03	69	132	3	EFO_0022341
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOB LIPC	3.94e-03	21	132	2	EFO_0022246
Disease	docosahexaenoic acid to total fatty acids percentage	APOB LIPC	3.94e-03	21	132	2	EFO_0022262
Disease	cholesteryl esters to total lipids in very small VLDL percentage	APOB LIPC TP53BP1	4.01e-03	71	132	3	EFO_0022259
Disease	triglycerides to total lipids in small HDL percentage	APOB LIPC TP53BP1	4.17e-03	72	132	3	EFO_0022336

Protein segments in the cluster

Peptide	Gene	Start	Entry
STMDPVQKAVISHTF	ZNF385C	51	Q66K41
KSQDPMAIFFTKGTT	ACSM6	216	Q6P461
TFVMPTVKTEASSQT	CAMTA1	641	Q9Y6Y1
EIAKTQMTPTNSVSF	APLF	151	Q8IW19
IVSGTTSITNMPEFK	ADGRG4	741	Q8IZF6
TFTASQTGLVSKDVM	ADGRG4	1921	Q8IZF6
GIENVKTYSTSFTPM	GSR	436	P00390
ATPMTLQTKGFTESL	AJAP1	226	Q9UKB5
KAYTVQTSESMTPTA	AFG1L	46	Q8WV93
STFQAKEMTSPLVSD	DEUP1	526	Q05D60
VPKSSSNEEVMFLTV	A2M	91	P01023
IATMTSVGKSGTINE	CCNB3	991	Q8WWL7
FPFTVTAAKGTTVKM	CNTN5	306	O94779
TPGTETSETQKAMIV	ANK2	3776	Q01484
SLSATVMVSKFTSPA	MUC16	991	Q8WXI7
SSPELVSKTTGMEFS	MUC16	3331	Q8WXI7
SKATSPMFITSTQED	MUC16	7206	Q8WXI7
GPNSESMIFETTTKN	NUP133	496	Q8WUM0
QITPEQSKRSTMVGT	PAK3	426	O75914
MSTNIVSEKTISFAG	OR5M11	81	Q96RB7
QTPTTFQETEMSPSK	MAP1B	1596	P46821
SSTMILFETTKSGPA	KIAA1671	141	Q9BY89
IPGSELMSSFAKTVV	TMPO	451	P42166
SMFPTSNTFTTDKIT	MGAM2	2316	Q2M2H8
NTMSPDTTVTSIDKF	MGAM2	2366	Q2M2H8
LFVQSFGIPVSSMSK	INTS1	1246	Q8N201
PITKTVEGTQVTMTC	GPIHBP1	116	Q8IV16
TKTSPNFMVLIATSV	MUC20	96	Q8N307
TTSTMLVSPAEGQVK	ELF4	376	Q99607
TPMTSQKTFESLVDF	HADH	186	Q16836
TLMKPSSFTTSFQAI	KIF18A	721	Q8NI77
PETSMIRTVNGKATV	KY	356	Q8NBH2
TSMQLKTPSGQVLSF	ATP9B	611	O43861
IINSTITPNMTFTKT	HOMER2	56	Q9NSB8
ITPNMTFTKTSQKFG	HOMER2	61	Q9NSB8
FKGIQVTATTPSMRA	KIAA1109	3161	Q2LD37
SSKMADVDISTVTGP	LOXHD1	1396	Q8IVV2
VGFATRQVASMTKPT	FABP3	26	P05413
STFPIDKSMTVVLTF	OR4A15	291	Q8NGL6
DTMEILSNSTSKFPT	OR51F1	6	A6NGY5
LSSVTAPKMITDFFS	OR4F5	66	Q8NH21
FTTFTKMETPSSTVA	MUC3A	1706	Q02505
PSEAVNMVSSQTKTV	OCC1	46	Q8TAD7
TFDTTKFGETMTPET	DEFB125	101	Q8N687
LPTSKSSQMITFTFA	PGM2	536	Q96G03
TATIAKTFPMAQLTS	PHF21A	291	Q96BD5
MTTTTTFKGVDPNSR	JPT1	1	Q9UK76
KMEVFIPLSTSAASS	EVC2	106	Q86UK5
TIVDFFKSLNPTGTM	LRRC74A	426	Q0VAA2
TPIQTTFTMSLLGTK	LIPC	366	P11150
IPQGADSTMLATKTV	NUP214	1061	P35658
GTQSLPTDVMTTVFK	LNPEP	851	Q9UIQ6
PTDVMTTVFKVGAKT	LNPEP	856	Q9UIQ6
SNKTEIITTPVGDFM	GABRE	251	P78334
MCKENVFPGTTTRTF	PRKCG	501	P05129
EQTYSMVKTGAPTVT	EPHA10	501	Q5JZY3
QETSVSISSTKGMFP	PTPRZ1	1086	P23471
LSSVTAPKMITDFFS	OR4F17	66	Q8NGA8
VSMVVSAGPLSSEKA	NBPF1	541	Q3BBV0
IINSTITPNMTFTKT	HOMER1	56	Q86YM7
ITPNMTFTKTSQKFG	HOMER1	61	Q86YM7
ESIKNSTPTVVMFGC	GRIN3A	316	Q8TCU5
VTSGMAPDTKETIFS	OPA1	406	O60313
VVMPFSSNTIEAHKS	PCDH15	1481	Q96QU1
EVSMTSPGQSKNFSL	DYRK4	496	Q9NR20
GNTKSKPTVSSSMEF	APOB	3446	P04114
DTTGVSQMFPSSKAR	FBF1	26	Q8TES7
NTMKVTAGISFAIPS	HTRA2	321	O43464
SIKMSAQAVVSTEAP	LINC01555	56	Q8NAE3
TKTKTAGPDQTEMTI	FN1	1676	P02751
TVDVSDMFSKPQSET	COL4A5	1651	P29400
DETMSPSTAFQVKVK	CNTN1	771	Q12860
MGRTPTAVQVKSFTK	BCE1	1	O60756
EPKSAFTQGSAMISS	CTSF	136	Q9UBX1
TKNTFEVFPMTSSGA	DIP2C	751	Q9Y2E4
RASGDVQTMKISSVP	DENND4C	1611	Q5VZ89
DTVEKVFSTTTAMPF	ANK3	1761	Q12955
QAMFDTLGIPKSTTS	FAM98B	151	Q52LJ0
TDFSGPLMIVTQKIT	MBOAT1	136	Q6ZNC8
TETGVVSPEQFMKSF	GNPNAT1	61	Q96EK6
HTAGSQMTDVTVTPK	KLF18	111	A0A0U1RQI7
MILSNTTAVTPFLTK	KCNE1	1	P15382
SVATIKFEMLSTAPQ	DALRD3	366	Q5D0E6
SKLVSVASTGTPAMV	GTF2IRD2	611	Q86UP8
TMVRPVAESGATKTS	S1PR4	146	O95977
SSVITPKMLVNFVSE	OR8A1	91	Q8NGG7
PTVMFSSFKNVKSVE	PRR14L	946	Q5THK1
IFMSETQSSPTKGVL	PIAS2	491	O75928
TVTVSETLGSPMSFF	OR4A4P	46	Q8NGN8
LSSVTAPKMITDFFS	OR4F4	66	Q96R69
SKVMPGASTKVETSA	GPRASP1	56	Q5JY77
NSKTAMVATVSPAAD	KIF13B	321	Q9NQT8
KSSSTMQVEPSFLQA	RTL4	6	Q6ZR62
QTAFGVMSTPEIKAT	RTL9	1086	Q8NET4
KVATPMSVTSQRFTV	TAF9B	171	Q9HBM6
ISHNSMEVTKTTFSP	RAP1GAP2	531	Q684P5
NSIISFSSVISMAKP	RPGRIP1	201	Q96KN7
GRQTVMTEKSTFQSV	SYNM	1361	O15061
MTEKSTFQSVVSESP	SYNM	1366	O15061
VSMVVSAGPLSSEKA	NBPF12	541	Q5TAG4
QTFPSEVVGKMVSSI	RIF1	126	Q5UIP0
QEMSGRAAATTPTKV	SYNPO	451	Q8N3V7
TLPQMFTKTLETQSA	SEC24A	601	O95486
ITGVESFMTKQDTTG	NCOA1	256	Q15788
SSMKVTSSIPVFDLQ	POGZ	356	Q7Z3K3
FAATGATPKSMINTT	NBEA	1826	Q8NFP9
TATQIKFPSTGVDTM	MED24	681	O75448
VGTKSDFITMNPSVV	ST8SIA4	181	Q92187
SSETTKIVPVDMQTG	SLC9A5	776	Q14940
MAATLFGKIPSSTVQ	RMDN2	326	Q96LZ7
GNSKTIMVATVSPAH	STARD9	351	Q9P2P6
VNVEFSMPTTSASKA	STON2	831	Q8WXE9
MNVTSLFSFTSPAVK	SMAD1	1	Q15797
KTLDPMVIFFTSGTT	ACSM1	216	Q08AH1
QTMPGASSSLVVKFA	CELF4	216	Q9BZC1
MLPFFSNTTSKSVSV	LINC00477	1	Q96M19
VTGMPVSAFTVILSK	COL10A1	546	Q03692
LTVPTQEGSFITKMA	TECTA	1921	O75443
TVKVFMTEPQSTFGK	XIRP2	1641	A4UGR9
MNKSQGSVSFTDVTV	ZFP1	1	Q6P2D0
MSTVSISVIKNPTVF	ZBTB37	66	Q5TC79
KTLVSTVGSMVFNEG	RRBP1	651	Q9P2E9
VPMSALKSVTSANFS	NUFIP2	401	Q7Z417
SIKTSFPMTVKVDGV	TMEM181	226	Q9P2C4
KSFGPVQSMTFVLET	REXO5	526	Q96IC2
VAFKSQQSTSMTPFG	ZNF398	296	Q8TD17
TPFLTKSGSSIMVEV	SPPL2B	366	Q8TCT7
TTLKTDGSPVMAAVQ	SREBF2	256	Q12772
HTMAQKTIFSTGTPV	SAP130	361	Q9H0E3
SSKTAPMQVLFSGEA	SMOX	506	Q9NWM0
TVSAIATTAMGSPKE	TNC	1701	P24821
EGKVMGTFSTVTSTV	SRPRA	371	P08240
GSTMPSVVKAAITFL	VWA5A	761	O00534
NVMEVSYPKTSTSLG	PREX2	941	Q70Z35
ALMGKISPVTFSVAS	SLC35E2B	316	P0CK96
AVAESVASPQKTMSV	TP53BP1	1021	Q12888
VSLFTEVSPKTAEMS	TTC23L	286	Q6PF05
SFAASVSIMGSDPKV	PITPNM3	746	Q9BZ71
CMKVGTSFSIPVVSD	EMG1	171	Q92979
SSMVSEVKTITEAGP	RELT	361	Q969Z4
IMSQFPSSKVASGEQ	TGFB1I1	111	O43294
SGVNKMLPSVSTTAI	ZMYM1	71	Q5SVZ6
DPSKVTSMSAVEFTP	PLXDC1	286	Q8IUK5
NPMNAVTTKFVRTST	WDR33	101	Q9C0J8
TTEIGMIGSKPFSTV	PLEKHA5	781	Q9HAU0
MSVSSGVQILTKPET	ZFP37	1	Q9Y6Q3
KFAGMPITLTVSTSS	SHC1	226	P29353
SLSNLFTMTVEVKGP	TMEM87A	201	Q8NBN3
SFQPITMSCKIVSGS	YEATS2	451	Q9ULM3
EMTTQAKSPESPFTV	GARIN5B	601	Q8N5Q1
SMTSIFPSAAVGLKN	N4BP2	1216	Q86UW6